Pharmaceutical combination
Combination of | |
---|---|
Estradiol | Estrogen |
Norethisterone acetate | Progestogen |
Clinical data | |
Trade names | Activella, Amabelz, CombiPatch, others |
AHFS/Drugs.com | Professional Drug Facts |
MedlinePlus | a601041 |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
![]() ![]() |
Estradiol/norethisterone acetate (E2/NETA), sold under the brand name Activella among others, is a combination of estradiol (E2) and norethisterone acetate (NETA) which is used in the treatment of vasomotor symptoms, vulvar and vaginal atrophy, and osteoporosis[1] associated with menopause.[2] Activella specifically is marketed by Novo Nordisk and is supplied as film-coated tablets containing 1 mg estradiol and 0.5 mg norethisterone acetate. CombiPatch is a combination of estradiol and NETA provided as a transdermal patch.[2]
See also
[edit]- Ethinylestradiol/norethisterone acetate
- Ethinylestradiol/norelgestromin
- Estradiol/levonorgestrel
- List of combined sex-hormonal preparations
References
[edit]- ^ Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, et al. (October 2002). "Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study". Journal of Bone and Mineral Research. 17 (10): 1904–12. doi:10.1359/jbmr.2002.17.10.1904. PMID 12369794. S2CID 29312298.
- ^ a b "CombiPatch (estradiol/norethindrone acetate transdermal system) Prescribing Information" (PDF). Noven Pharmaceuticals, Inc. U.S. Food and Drug Administration.
Progestogens (and progestins) |
| ||||
---|---|---|---|---|---|
Antiprogestogens |
| ||||
|
ERTooltip Estrogen receptor |
| ||||||
---|---|---|---|---|---|---|---|
GPERTooltip G protein-coupled estrogen receptor |
| ||||||
PRTooltip Progesterone receptor |
| ||||||
---|---|---|---|---|---|---|---|
mPRTooltip Membrane progesterone receptor (PAQRTooltip Progestin and adipoQ receptor) |
| ||||||